logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Pharmaceutical
Filter

Pharmaceutical

Categories

Sectors

Locations

Exchange

Shanghai Henlius Announces $192.5 Million Funding for Biosimilars, Novel mAbs

Dec 29, 2017

Life Science

Cellular Biomedicine Group Announces Closing of $14.5M Private Placement Offering

Dec 28, 2017

Life Science

Shanghai’s SARI to Acquire NMS, an Italian Oncology Company, for $359 Million

Dec 28, 2017

Life Science

Kangning to Raise $30 Million in China Psychiatric Hospital IPO

Dec 28, 2017

Life Science

Merck Serono, WuXi AppTec and Pontifax Form Israeli Life Science Incubator

Dec 27, 2017

Life Science

Asieris Pharma Closes $15 Million B Round Financing

Dec 27, 2017

Life Science

CG Capital of Beijing to Acquire 37% of NovaBay for $28 Million

Dec 27, 2017

Life Science

Big tech’s spending on healthcare equity deals up 875% in 5 years: What 5 tech giants are up to

Dec 27, 2017

Life Science

DelMar Pharmaceuticals Inc NASDAQ:DMPI

DelMar Pharmaceuticals Announces Fast Track Designation for VAL-083 in Recurrent Glioblastoma

Dec 27, 2017

Life Science

Nanjing Legend Lands $350 Million Upfront for CAR-T Partnership with Janssen

Dec 22, 2017

Life Science

Yonghua Capital Leads $25 Million B Round in Taris Biomedical

Dec 22, 2017

Life Science

Huadong Medicine Enters $83 Million Deal for GLP-1r Diabetes Treatment

Dec 22, 2017

Life Science

China’s I-Mab Inks $548 Million Immunoncology Pact with Genexine

Dec 22, 2017

Life Science

CANbridge Files to Start China Trials of Esophageal Cancer Treatment

Dec 21, 2017

Life Science

Ambrx Enters $143.5 Million China Deal for Liver Cancer Treatment

Dec 21, 2017

Life Science

Zai Lab Pays $44 Million for China Rights to Gastric Cancer Immunotherapy

Dec 20, 2017

Life Science

BeiGene Initiates Pivotal Trial of PARP inhibitor Pamiparib (BGB-290) in China in Patients With Ovarian Cancer

Dec 18, 2017

Life Science

Novartis Buys Rare Drug Voucher for $130M From Ultragenyx

Dec 18, 2017

Life Science

  • ‹‹ Previous
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada